Literature DB >> 21158315

Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.

R K Doot1, J S Scheuermann, P E Christian, J S Karp, P E Kinahan.   

Abstract

PURPOSE: The variances and biases inherent in quantifying PET tracer uptake from instrumentation factors are needed to ascertain the significance of any measured differences such as in quantifying response to therapy. The authors studied the repeatability and reproducibility of serial PET measures of activity as a function of object size, acquisition, reconstruction, and analysis method on one scanner and at three PET centers using a single protocol with long half-life phantoms.
METHODS: The authors assessed standard deviations (SDs) and mean biases of consecutive measures of PET activity concentrations in a uniform phantom and a NEMA NU-2 image quality (IQ) phantom filled with 9 months half-life 68Ge in an epoxy matrix. Activity measurements were normalized by dividing by a common decay corrected true value and reported as recovery coefficients (RCs). Each experimental set consisted of 20 consecutive PET scans of either a stationary phantom to evaluate repeatability or a repositioned phantom to assess reproducibility. One site conducted a comprehensive series of repeatability and reproducibility experiments, while two other sites repeated the reproducibility experiments using the same IQ phantom. An equation was derived to estimate the SD of a new PET measure from a known SD based on the ratios of available coincident counts between the two PET measures.
RESULTS: For stationary uniform phantom scans, the SDs of maximum RCs were three to five times less than predicted for uncorrelated pixels within circular regions of interest (ROIs) with diameters ranging from 1 to 15 cm. For stationary IQ phantom scans from 1 cm diameter ROIs, the average SDs of mean and maximum RCs ranged from 1.4% to 8.0%, depending on the methods of acquisition and reconstruction (coefficients of variation range 2.5% to 9.8%). Similar SDs were observed for both analytic and iterative reconstruction methods (p > or = 0.08). SDs of RCs for 2D acquisitions were significantly higher than for 3D acquisitions (p < or =s 0.008) for same acquisition and processing parameters. SDs of maximum RCs were larger than corresponding mean values for stationary IQ phantom scans ( < or = 0.02), although the magnitude of difference is reduced due to noise correlations in the image. Increased smoothing decreased SDs ( < or =s 0.045) and decreased maximum and mean RCs (p < or = 0.02). Reproducibility of GE DSTE, Philips Gemini TF, and Siemens Biograph Hi-REZ PET/CT scans of the same IQ phantom, with similar acquisition, reconstruction, and repositioning among 20 scans, were, in general, similar (mean and maximum RC SD range 2.5% to 4.8%).
CONCLUSIONS: Short-term scanner variability is low compared to other sources of error. There are tradeoffs in noise and bias depending on acquisition, processing, and analysis methods. The SD of a new PET measure can be estimated from a known SD if the ratios of available coincident counts between the two PET scanner acquisitions are known and both employ the same ROI definition. Results suggest it is feasible to use PET/CTs from different vendors and sites in clinical trials if they are properly cross-calibrated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21158315      PMCID: PMC2988835          DOI: 10.1118/1.3499298

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  33 in total

1.  Variability in PET quantitation within a multicenter consortium.

Authors:  Frederic H Fahey; Paul E Kinahan; Robert K Doot; Mehmet Kocak; Harold Thurston; Tina Young Poussaint
Journal:  Med Phys       Date:  2010-07       Impact factor: 4.071

Review 2.  How should we analyse FDG PET studies for monitoring tumour response?

Authors:  Adriaan A Lammertsma; Corneline J Hoekstra; Giuseppe Giaccone; Otto S Hoekstra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

3.  Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study.

Authors:  V Bettinardi; P Mancosu; M Danna; G Giovacchini; C Landoni; M Picchio; M C Gilardi; A Savi; I Castiglioni; M Lecchi; F Fazio
Journal:  Q J Nucl Med Mol Imaging       Date:  2007-04-30       Impact factor: 2.346

Review 4.  Standards for PET image acquisition and quantitative data analysis.

Authors:  Ronald Boellaard
Journal:  J Nucl Med       Date:  2009-04-20       Impact factor: 10.057

5.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.

Authors:  Ronald Boellaard; Wim J G Oyen; Corneline J Hoekstra; Otto S Hoekstra; Eric P Visser; Antoon T Willemsen; Bertjan Arends; Fred J Verzijlbergen; Josee Zijlstra; Anne M Paans; Emile F I Comans; Jan Pruim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

6.  Reproducibility of metabolic measurements in malignant tumors using FDG PET.

Authors:  W A Weber; S I Ziegler; R Thödtmann; A R Hanauske; M Schwaiger
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

7.  Powerful prognostic stratification by [18F]fluorodeoxyglucose positron emission tomography in patients with metastatic breast cancer treated with high-dose chemotherapy.

Authors:  Florent Cachin; H Miles Prince; Annette Hogg; Robert E Ware; Rodney J Hicks
Journal:  J Clin Oncol       Date:  2006-05-22       Impact factor: 44.544

8.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

9.  Reproducibility of semi-quantitative parameters in FDG-PET using two different PET scanners: influence of attenuation correction method and examination interval.

Authors:  Tomohito Kamibayashi; Tatsuro Tsuchida; Yoshiki Demura; Tetsuya Tsujikawa; Hidehiko Okazawa; Takashi Kudoh; Hirohiko Kimura
Journal:  Mol Imaging Biol       Date:  2008-04-12       Impact factor: 3.488

10.  PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

Authors:  Florian Lordick; Katja Ott; Bernd-Joachim Krause; Wolfgang A Weber; Karen Becker; Hubert J Stein; Sylvie Lorenzen; Tibor Schuster; Hinrich Wieder; Ken Herrmann; Rainer Bredenkamp; Heinz Höfler; Ulrich Fink; Christian Peschel; Markus Schwaiger; Jörg R Siewert
Journal:  Lancet Oncol       Date:  2007-09       Impact factor: 41.316

View more
  37 in total

1.  Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.

Authors:  Wolfgang A Weber; Constantine A Gatsonis; P David Mozley; Lucy G Hanna; Anthony F Shields; Denise R Aberle; Ramaswamy Govindan; Drew A Torigian; Joel S Karp; Jian Q Michael Yu; Rathan M Subramaniam; Robert A Halvorsen; Barry A Siegel
Journal:  J Nucl Med       Date:  2015-04-23       Impact factor: 10.057

2.  A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy.

Authors:  Kristen A Wangerin; Mark Muzi; Lanell M Peterson; Hannah M Linden; Alena Novakova; David A Mankoff; Paul E Kinahan
Journal:  Phys Med Biol       Date:  2017-02-13       Impact factor: 3.609

3.  Assessment of patient selection criteria for quantitative imaging with respiratory-gated positron emission tomography.

Authors:  Stephen R Bowen; Larry A Pierce; Adam M Alessio; Chi Liu; Scott D Wollenweber; Charles W Stearns; Paul E Kinahan
Journal:  J Med Imaging (Bellingham)       Date:  2014-09-24

4.  Longitudinal monitoring of reconstructed activity concentration on a clinical time-of-flight PET/CT scanner.

Authors:  Lawrence R MacDonald; Amy E Perkins; Chi-Hua Tung
Journal:  J Med Imaging (Bellingham)       Date:  2016-11-23

Review 5.  Quantitative assessment of dynamic PET imaging data in cancer imaging.

Authors:  Mark Muzi; Finbarr O'Sullivan; David A Mankoff; Robert K Doot; Larry A Pierce; Brenda F Kurland; Hannah M Linden; Paul E Kinahan
Journal:  Magn Reson Imaging       Date:  2012-07-21       Impact factor: 2.546

6.  Noise considerations for PET quantification using maximum and peak standardized uptake value.

Authors:  Martin A Lodge; Muhammad A Chaudhry; Richard L Wahl
Journal:  J Nucl Med       Date:  2012-05-24       Impact factor: 10.057

Review 7.  Towards enhanced PET quantification in clinical oncology.

Authors:  Habib Zaidi; Nicolas Karakatsanis
Journal:  Br J Radiol       Date:  2017-11-22       Impact factor: 3.039

8.  Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements.

Authors:  Robert K Doot; Larry A Pierce; Darrin Byrd; Brian Elston; Keith C Allberg; Paul E Kinahan
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

9.  A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment.

Authors:  Robert L Harrison; Brian F Elston; Robert K Doot; Thomas K Lewellen; David A Mankoff; Paul E Kinahan
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

10.  Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings.

Authors:  Virendra Kumar; Kavindra Nath; Claudia G Berman; Jongphil Kim; Tawee Tanvetyanon; Alberto A Chiappori; Robert A Gatenby; Robert J Gillies; Edward A Eikman
Journal:  Clin Nucl Med       Date:  2013-03       Impact factor: 7.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.